News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,294 Results
Type
Article (8015)
Company Profile (139)
Press Release (475044)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166759)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238243)
Policy (17922)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (482)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33154)
ALS (102)
Alzheimer's disease (967)
Antibody-drug conjugate (ADC) (256)
Approvals (10344)
Artificial intelligence (311)
ASCO (159)
Autoimmune disease (197)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (104)
Biotechnology (88)
Bladder cancer (133)
Brain cancer (28)
Breast cancer (501)
Cancer (3571)
Cardiovascular disease (214)
Career advice (245)
Career pathing (1)
CAR-T (169)
Celiac Disease (1)
Cell therapy (469)
Cervical cancer (34)
Clinical research (47754)
Collaboration (1209)
Commercialization (1)
Compensation (1395)
Complete response letters (33)
COVID-19 (750)
CRISPR (63)
C-suite (713)
Cystic fibrosis (84)
Data (5524)
Denatured (4)
Depression (101)
Dermatology (60)
Diabetes (336)
Diagnostics (4156)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (147)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (159)
Earnings (73061)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87456)
Executive appointments (683)
FDA (12298)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (895)
Gene editing (125)
Generative AI (9)
Gene therapy (309)
GLP-1 (286)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9307)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (61)
Immunology and inflammation (97)
Immuno-oncology (55)
Indications (151)
Infectious disease (936)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (41)
IPO (12379)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (493)
Lymphoma (242)
Machine learning (27)
Management (3)
Manufacturing (513)
Marketing (7)
MASH (116)
Medical device (8638)
Medtech (8762)
Mergers & acquisitions (14355)
Metabolic disorders (692)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (213)
Neuropsychiatric disorders (38)
Neuroscience (1788)
NextGen: Class of 2026 (3150)
Non-profit (842)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (169)
Pancreatic cancer (191)
Parkinson's disease (196)
Partnered (11)
Patents (458)
Patient recruitment (479)
Peanut (31)
People (41128)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15434)
Phase 2 (21324)
Phase 3 (14360)
Pipeline (6688)
Policy (18)
Postmarket research (1570)
Preclinical (6526)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (558)
Real estate (3019)
Recruiting (6)
Regulatory (14699)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (149)
Series B (118)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (49)
Vaccines (311)
Venture capital (17)
Weight loss (72)
Women's health (75)
Date
Today (67)
Last 7 days (279)
Last 30 days (1118)
Last 365 days (19091)
2026 (10836)
2025 (19251)
2024 (22985)
2023 (26541)
2022 (34593)
2021 (37168)
2020 (33479)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24268)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (71)
Alaska (2)
Arizona (294)
Arkansas (11)
Asia (17846)
Australia (2090)
California (11545)
Canada (3047)
China (506)
Colorado (465)
Connecticut (392)
Delaware (204)
Europe (24566)
Florida (1719)
Georgia (364)
Hawaii (3)
Idaho (46)
Illinois (680)
India (42)
Indiana (308)
Iowa (13)
Japan (387)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1156)
Massachusetts (7600)
Michigan (299)
Minnesota (540)
Mississippi (4)
Missouri (78)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2543)
New Mexico (12)
New York (2738)
North Carolina (1231)
North Dakota (4)
Northern California (5750)
Ohio (269)
Oklahoma (14)
Oregon (14)
Pennsylvania (2193)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4789)
Tennessee (114)
Texas (1862)
United States (37563)
Utah (345)
Vermont (1)
Virginia (146)
Washington D.C. (38)
Washington State (896)
West Virginia (1)
Wisconsin (73)
483,294 Results for "kardium inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kardium receives FDA approval of the Globe® Pulsed Field System
September 4, 2025
·
2 min read
Press Releases
Kardium Announces $250M (CA$340M) Financing to Launch Innovative Atrial Fibrillation Treatment
July 2, 2025
·
3 min read
Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment
Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $104 million in a new financing round.
June 11, 2024
·
2 min read
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study
Kardium Inc. announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study.
April 2, 2024
·
3 min read
Press Releases
Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System
April 28, 2025
·
3 min read
Kardium Announces Enhanced Clinical Capabilities of the Globe® System With Right Atrial Ablation and Hybrid Energy Ablation
Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation, announced that it had successfully treated a series of patients delivering therapy in both the left and right atria.
May 9, 2024
·
3 min read
Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation
Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe ® System, showing promise for improving the treatment of atrial fibrillation.
May 29, 2024
·
2 min read
Successful First-in-Human Clinical Study of Kardium’s Next Generation Globe® Pulsed Field System
Kardium Inc. announces the successful first-in-human study of its next generation Globe® Pulsed Field System to treat atrial fibrillation (AF) using pulsed field ablation (PFA) therapy.
November 8, 2022
·
3 min read
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first US patients have been successfully treated in the PULSAR clinical study.
May 31, 2023
·
2 min read
Kardium Announces First Patients Treated in PULSAR IDE Study of Globe® Pulsed Field System
Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first patients have been successfully treated in its PULSAR clinical study.
March 15, 2023
·
3 min read
1 of 48,330
Next
